posted on 2023-02-09, 13:43authored byMaria Antonietta Cerone, Tara C Mills, Rowena Sharpe, David McBride, Moira MacDonald, Suzanne MacMahon, Hood Mugalaasi, Pauline Rehal, Alessandro Rettino, Helen Roberts, Mark Ross, Donald Edward White, John Peden, Janette Rawlinson, Steffan N Ho, Simon Hollingsworth, Sanjay Popat, Gary Middleton, Peter Johnson, Charles Swanton, SMP2 consortium
Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies.
Funding
Crick (Grant ID: CC2041, Grant title: Swanton CC2041)